RNA
Avidity Biosciences (RNA)
$56
About Avidity Biosciences (RNA)
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Details
Daily high
$31.88
Daily low
$30.33
Price at open
$30.39
52 Week High
$56.00
52 Week Low
$21.56
Market cap
3.7B
Dividend yield
0.00%
Volume
627,065
Avg. volume
1.3M
P/E ratio
-10.51
Avidity Biosciences News
Details
Daily high
$31.88
Daily low
$30.33
Price at open
$30.39
52 Week High
$56.00
52 Week Low
$21.56
Market cap
3.7B
Dividend yield
0.00%
Volume
627,065
Avg. volume
1.3M
P/E ratio
-10.51